Cancer cases are on the rise, presenting an increasingly pressing challenge in healthcare today. While the field of oncology has made significant strides over the years, one persistent issue remains: the current system of cancer medication often falls short of reaching all the cancer cells effectively. Traditional treatments like chemotherapy and immunotherapy have struggled to penetrate hard-to-reach areas within tumors, known as hypoxic zones, due to damaged or collapsed blood vessels in tumors. These hypoxic zones are home to cancer stem cells, which play a critical role in metastasis, making their elimination vital for successful treatment. For decades, the inability to address this crucial problem has left many cancer patients with limited options.